Zimmer Biomet Holdings (ZBH) Short-Term Debt issuances (2014 - 2025)
Zimmer Biomet Holdings (ZBH) posted quarterly Short-Term Debt issuances of $220.0 million for Q2 2025, up 388.89% year-over-year from $45.0 million in Q2 2024, and up 438.46% quarter-over-quarter from -$65.0 million in Q3 2024.
Zimmer Biomet Holdings (ZBH) Short-Term Debt issuances (2014 - 2025) Analysis & Trends
Zimmer Biomet Holdings' Short-Term Debt issuances history runs 9 years deep, the most recent figure standing at $220.0 million for Q2 2025.
- In Q2 2025, Short-Term Debt issuances rose 388.89% year-over-year to $220.0 million; the TTM figure through Jun 2025 stood at $155.0 million (down 47.46% YoY), while the FY2024 annual figure was $50.0 million, down 84.62% from the prior year.
- Short-Term Debt issuances for Q2 2025 stood at $220.0 million, up from -$65.0 million in the prior quarter.
- The five-year high for Short-Term Debt issuances was $305.0 million in Q4 2023, with the low at -$125.0 million in Q3 2023.
- The 4-year median for Short-Term Debt issuances is $100.0 million (2022), against an average of $88.2 million.
- The sharpest annual moves came in 2023 and 2025: Short-Term Debt issuances plunged 154.17% in 2023, then soared 388.89% in 2025.
- Zimmer Biomet Holdings' Short-Term Debt issuances stood at $155.0 million in 2022, then soared by 96.77% to $305.0 million in 2023, then plunged by 121.31% to -$65.0 million in 2024, then surged by 438.46% to $220.0 million in 2025.
- Business Quant data shows ZBH's Short-Term Debt issuances at $220.0 million in Q2 2025, -$65.0 million in Q3 2024, and $45.0 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 64.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -164.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.42 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -47.66 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -37.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 220.00 Mn |
| Jun 30, 2025 | 220.00 Mn |
| Sep 30, 2024 | -65.00 Mn |
| Sep 30, 2024 | -65.00 Mn |
| Jun 30, 2024 | 45.00 Mn |
| Jun 30, 2024 | 45.00 Mn |
| Mar 31, 2024 | 70.00 Mn |
| Mar 31, 2024 | 70.00 Mn |
| Dec 31, 2023 | 305.00 Mn |
| Dec 31, 2023 | 305.00 Mn |
| Sep 30, 2023 | -125.00 Mn |
| Sep 30, 2023 | -125.00 Mn |
| Jun 30, 2023 | -65.00 Mn |
| Jun 30, 2023 | -65.00 Mn |
| Mar 31, 2023 | 210.00 Mn |
| Mar 31, 2023 | 210.00 Mn |
| Dec 31, 2022 | 155.00 Mn |
| Dec 31, 2022 | 155.00 Mn |
| Jun 30, 2022 | 120.00 Mn |
| Jun 30, 2022 | 120.00 Mn |